-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, ofl+kMRY32XPnwz+eQD3GdMxFaNqDJksQidbpLR9qyHL5D+QY21igzLBf4XIM7Pg n03t3xneNExPth4ypu6FMA== 0000812295-94-000047.txt : 19940811 0000812295-94-000047.hdr.sgml : 19940811 ACCESSION NUMBER: 0000812295-94-000047 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19940810 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN INC CENTRAL INDEX KEY: 0000714655 STANDARD INDUSTRIAL CLASSIFICATION: 2836 IRS NUMBER: 043002117 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-35348 FILM NUMBER: 94542528 BUSINESS ADDRESS: STREET 1: 14 CAMBRIDGE CTR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6172529200 MAIL ADDRESS: ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN NV DATE OF NAME CHANGE: 19880622 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JANUS CAPITAL CORP CENTRAL INDEX KEY: 0000812295 STANDARD INDUSTRIAL CLASSIFICATION: 0000 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 100 FILLMORE STREET SUITE 300 CITY: DENVER STATE: CO ZIP: 80206-4923 BUSINESS PHONE: 303-333-38 MAIL ADDRESS: STREET 1: 100 FILLMORE STREET SUITE 300 CITY: DENVER STATE: CO ZIP: 80206-4923 SC 13G 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No.: * Name of Issuer: Biogen, Inc. Title of Class of Securities: Common Stock CUSIP Number: 09059710-5 Check the following line if a fee is being paid with this statement _X_. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.)(See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.: 09059710-5 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Janus Capital Corporation EIN #84-0765359 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP a. ___ b. _X_ 3. SEC USE ONLY 4. CITIZENSHIP OF PLACE OF ORGANIZATION Colorado NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5. SOLE VOTING POWER -0- 6. SHARED VOTING POWER 3,465,100 7. SOLE DISPOSITIVE POWER -0- 8. SHARED DISPOSITIVE POWER 3,465,100 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,465,100 ** 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES N/A 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.7% 12. TYPE OF REPORTING PERSON IA, CO ** See Item 4 of this filing CUSIP No.: 09059710-5 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Kansas City Southern Industries, Inc. EIN #44-0663509 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP a. ___ b. _X_ 3. SEC USE ONLY 4. CITIZENSHIP OF PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5. SOLE VOTING POWER -0- 6. SHARED VOTING POWER -0- 7. SOLE DISPOSITIVE POWER -0- 8. SHARED DISPOSITIVE POWER -0- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -0- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 3,465,100 ** Excludes shares that may be beneficially owned by Janus Capital Corporation as to which beneficial ownership is disclaimed. 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) -0- 12. TYPE OF REPORTING PERSON HC, CO ** See Item 4 of this filing CUSIP No.: 09059710-5 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Thomas H. Bailey SS ####-##-#### 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP a. ___ b. _X_ 3. SEC USE ONLY 4. CITIZENSHIP OF PLACE OF ORGANIZATION USA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5. SOLE VOTING POWER -0- 6. SHARED VOTING POWER 3,465,100 7. SOLE DISPOSITIVE POWER -0- 8. SHARED DISPOSITIVE POWER 3,465,100 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,465,100 ** 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES N/A 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.7% 12. TYPE OF REPORTING PERSON IN ** See Item 4 of this filing Item 1. (a). Name of Issuer: Biogen, Inc. ("Biogen") (b). Address of Issuer's Principal Executive Offices: 14 Cambridge Center Cambridge, MA 02142 Item 2. (a).(b). Name and Principal Business Address of Persons Filing: (1) Janus Capital Corporation ("Janus Capital") 100 Fillmore Street, Suite 300 Denver, Colorado 80206-4923 (2) Kansas City Southern Industries, Inc. ("KCSI") 114 West 11th Street Kansas City, Missouri 64105 (3) Thomas H. Bailey ("Mr. Bailey") 100 Fillmore Street, Suite 300 Denver, Colorado 80206-4923 (c). Citizenship: Janus Capital - Colorado KCSI - Delaware Mr. Bailey - USA (d). Title of Class of Securities: Common Stock (e). CUSIP Number: 09059710-5 Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: (a). Broker or Dealer registered under Section 15 of the Act (b). Bank as defined in Section 3(a)(6) of the Act (c). Insurance Company as defined in Section 3(a)(19) of the Act (d). Investment Company registered under Section 8 of the Investment Company Act (e). X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 (f). Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see Section 240.13d-1(b)(ii)(F) (g). X Parent Holding Company, in accordance with Section 240.13d-1(b)(ii)(G) (Note: See Item 7) (h). Group, in accordance with Section 240.13(d)-1(b)(1)(ii)(H) KCSI owns approximately 81% and Mr. Bailey owns approximately 17.6% of Janus Capital (which is a registered investment adviser). KCSI is filing this joint statement solely as a result of such stock ownership which may be deemed to give it the ability to exert control over Janus Capital. In addition to being a stockholder of Janus Capital, Mr. Bailey serves as President and Chairman of the Board of Janus Capital and is filing this joint statement with Janus Capital as a result of such stock ownership and positions which may be deemed to enable him to exercise control over Janus Capital. Item 4. Ownership (a). Amount Beneficially Owned: KCSI and Mr. Bailey do not own of record any shares of Biogen Common Stock, they have not engaged in any transaction in Biogen Common Stock, and they do not exercise any voting or investment power over shares of Biogen Common Stock. However, Mr. Bailey may be deemed to have the power to exercise or to direct the exercise of such voting and/or dispositive power that Janus Capital may have with respect to Biogen Common Stock held by Janus Capital's individual, institutional and mutual fund clients, as a result of his position as Chairman of the Board and President of Janus Capital. All shares reported herein have been acquired by such clients, and KCSI and Mr. Bailey specifically disclaim beneficial ownership over any shares of Biogen Common Stock that they or Janus Capital may be deemed to beneficially own. Janus Capital is a registered investment adviser which furnishes investment advice to individual and institutional clients ("Separately Managed Accounts"), to Janus Investment Fund ("JIF"), series of which include Janus Fund, Janus Twenty Fund, Janus Venture Fund, Janus Growth and Income Fund, Janus Worldwide Fund, Janus Balanced Fund and Janus Mercury Fund (the "Janus Funds") and to Janus Aspen Series ("Aspen"), series of which include Janus Aspen Series - Growth Portfolio ("Aspen Growth"), Janus Aspen Series - Aggressive Growth Portfolio ("Aspen Aggressive Growth"), Janus Aspen Series - Worldwide Growth Portfolio ("Aspen Worldwide") and Janus Aspen Series - Balanced Portfolio ("Aspen Balanced"), referred to herein collectively as the Aspen Funds. JIF and Aspen are open-end management investment companies registered under the Investment Company Act of 1940 ("1940 Act"). Janus Capital is also a 50% owner of Idex Management, Inc. which serves as the investment adviser to the mutual funds in the IDEX Group, including IDEX II Global Portfolio ("IDEX Global"), which is an open-end management investment company registered under the 1940 Act. Janus Capital furnishes investment advice to Idex Management, Inc. and serves as sub-adviser to IDEX Global. Janus Capital serves as a sub-adviser to Western Reserve Life Assurance Co. of Ohio which is the adviser to WRL Series Fund, Inc., an open-end management investment company registered under the 1940 Act, one portfolio of which is WRL Series Fund, Inc. - Global Portfolio ("WRL Global"). Janus Capital furnishes investment advice to WRL Global. As a result of its role as investment adviser or sub- adviser to the Janus Funds, Aspen Funds, IDEX Global, WRL Global and to the Separately Managed Accounts, Janus Capital may be deemed to be the beneficial owner of the shares of Biogen Common Stock held by such funds and accounts. In addition, due to his position as Chairman of the Board and President of Janus Capital, Mr. Bailey may be deemed to share beneficial ownership over such shares of Biogen Common Stock. However, Janus Capital and Mr. Bailey disclaim such ownership. Accordingly, the filing of this statement shall not be construed as an admission that KCSI, Mr. Bailey or Janus Capital are, for purposes of Sections 13(d) or 13(g) of the Act, the beneficial owner of any securities covered by this statement. Janus Fund 1,143,325 Janus Twenty Fund 556,950 Janus Venture Fund 497,625 Janus Growth and Income Fund 223,000 Janus Worldwide Fund 410,450 Janus Balanced Fund 25,000 Janus Mercury Fund 216,825 IDEX Global 23,200 WRL Global 64,900 Aspen Growth 7,000 Aspen Aggressive Growth 8,850 Aspen Worldwide 7,700 Aspen Balanced 1,000 Separately Managed Accounts 279,275 Total 3,465,100 (b). Percent of Class: Janus Fund 3.5% Janus Twenty Fund 1.7% Janus Venture Fund 1.5% Janus Growth and Income Fund .7% Janus Worldwide Fund 1.3% Janus Balanced Fund .1% Janus Mercury Fund .7% IDEX Global .1% WRL Global .2% Aspen Growth * Aspen Aggressive Growth * Aspen Worldwide * Aspen Balanced * Separately Managed Accounts .9% Total 10.7% * Less than .1%. (c). Number of shares as to which such person has: (i). sole power to vote or to direct the vote 0 (ii). shared power to vote or to direct the vote Janus Fund 1,143,325 Janus Twenty Fund 556,950 Janus Venture Fund 497,625 Janus Growth and Income Fund 223,000 Janus Worldwide Fund 410,450 Janus Balanced Fund 25,000 Janus Mercury Fund 216,825 IDEX Global 23,200 WRL Global 64,900 Aspen Growth 7,000 Aspen Aggressive Growth 8,850 Aspen Worldwide 7,700 Aspen Balanced 1,000 Separately Managed Accounts 279,275 Total 3,465,100 (iii). sole power to dispose or to direct the disposition of 0 (iv). shared power to dispose or to direct the disposition of Janus Fund 1,143,325 Janus Twenty Fund 556,950 Janus Venture Fund 497,625 Janus Growth and Income Fund 223,000 Janus Worldwide Fund 410,450 Janus Balanced Fund 25,000 Janus Mercury Fund 216,825 IDEX Global 23,200 WRL Global 64,900 Aspen Growth 7,000 Aspen Aggressive Growth 8,850 Aspen Worldwide 7,700 Aspen Balanced 1,000 Separately Managed Accounts 279,275 Total 3,465,100 Item 5. Ownership of Five Percent or Less of a Class N/A Item 6. Ownership of More than Five Percent on Behalf of Another Person Janus Capital's Separately Managed Account clients and mutual funds, set forth in Item 4 above, have the right to receive all dividends from, and the proceeds from the sale of, the securities held in their respective accounts. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company KCSI is the majority owner of Janus Capital, a registered investment adviser and joint filer of this statement. Item 8. Identification and Classification of Members of the Group N/A Item 9. Notice of Dissolution of Group N/A Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. JANUS CAPITAL CORPORATION By /s/ David C. Tucker 8/9/94 David C. Tucker, Vice President Date KANSAS CITY SOUTHERN INDUSTRIES, INC. By /s/ David C. Tucker 8/9/94 David C. Tucker Date Under Power of Attorney dated 2/10/94 On File with Schedule 13G for Navigators Group, Inc. 2/11/94 THOMAS H. BAILEY By /s/ David C. Tucker 8/9/94 David C. Tucker Date Under Power of Attorney dated 2/10/94 On File with Schedule 13G for Navigators Group, Inc. 2/11/94 EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Biogen, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned hereby execute this Agreement as of the 9th day of August , 1994. JANUS CAPITAL CORPORATION By /s/ David C. Tucker David C. Tucker, Vice President KANSAS CITY SOUTHERN INDUSTRIES, INC. By /s/ David C. Tucker David C. Tucker Under Power of Attorney dated 2/10/94 On File with Schedule 13G for Navigators Group, Inc. 2/11/94 THOMAS H. BAILEY By /s/ David C. Tucker David C. Tucker Under Power of Attorney dated 2/10/94 On File with Schedule 13G for Navigators Group, Inc. 2/11/94 -----END PRIVACY-ENHANCED MESSAGE-----